Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
9MB
[thumbnail of Supplementary Data] Other (Supplementary Data)
6MB

Item Type:Article
Title:Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types
Creators Name:Gustafsson, Oskar, Krishna, Supriya, Borate, Sophia, Ghaeidamini, Marziyeh, Liang, Xiuming, Saher, Osama, Cuellar, Raul, Birdsong, Björn K, Roudi, Samantha, Estupiñán, H Yesid, Alici, Evren, Smith, C I Edvard, Esbjörner, Elin K, Spuler, Simone, de Jong, Olivier Gerrit, Escobar, Helena, Nordin, Joel Z and Andaloussi, Samir E L
Abstract:Efficient delivery of the CRISPR/Cas9 system and its larger derivatives, base editors, and prime editors remain a major challenge, particularly in tissue-specific stem cells and induced pluripotent stem cells (iPSCs). This study optimized a novel family of cell-penetrating peptides, hPep, to deliver gene-editing ribonucleoproteins. The hPep-based nanoparticles enable highly efficient and biocompatible delivery of Cre recombinase, Cas9, base-, and prime editors. Using base editors, robust and nearly complete genome editing was achieved in the human cells: HEK293T (96%), iPSCs (74%), and muscle stem cells (80%). This strategy opens promising avenues for ex vivo and, potentially, in vivo applications. Incorporating silica particles enhanced the system’s versatility, facilitating cargo-agnostic delivery. Notably, the nanoparticles can be synthesized quickly on a benchtop and stored as lyophilized powder without compromising functionality. This represents an important advancement in the feasibility and scalability of gene-editing delivery technologies.
Keywords:Synthetic Gene Editor Delivery, Protein Delivery, Cell-Penetrating Peptide (CPP), Diverse Cells, Including MuSC and iPSC, Gene Editing, Base and Primer Editor
Source:Journal of Controlled Release
ISSN:0168-3659
Publisher:Elsevier
Volume:386
Page Range:114038
Date:10 October 2025
Official Publication:https://doi.org/10.1016/j.jconrel.2025.114038
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library